*Reed Smith

This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

viewpoints

Welcome to Reed Smith's viewpoints — timely commentary from our lawyers on topics relevant to your business and wider industry. Browse to see the latest news and subscribe to receive updates on topics that matter to you, directly to your mailbox.

3 results for: radiopharmaceuticals

7/31/2023 4:10:46 PM

An appeal to CMS for common sense relief from unnecessary burdens when billing for imaging contrast agent and radiopharmaceutical reimbursement

By Tom Greeson

In a joint letter to the Centers for Medicaid & Medicare Services (CMS), the American College of Radiology (ACR), the Radiology Business...

7/26/2022 8:27:43 PM

An innovation in nuclear medicine brings an important cancer detection test to many more U.S. communities

By Tom Greeson

Today, I'm sharing an account of the benefits of a new diagnostic test for patients who live in Central Illinois. It illustrates how an...

2/8/2022 7:17:08 PM

NRC leaves stringent "authorized user" of radiopharmaceuticals requirements in place

By Tom Greeson

The United States Nuclear Regulatory Commission (NRC) has voted to maintain stringent training and education (T&E) requirements for...

Evan Knott admitted to American College of Coverage Counsel

Industries

Services

Business Teams

Reed Smith named a 2025 ACC Value Champion

An appeal to CMS for common sense relief from unnecessary burdens when billing for imaging contrast agent and radiopharmaceutical reimbursement

An innovation in nuclear medicine brings an important cancer detection test to many more U.S. communities

NRC leaves stringent "authorized user" of radiopharmaceuticals requirements in place